May 2017 - Sperling Prostate Center

How Additional Treatments after Prostatectomy Affect Quality of Life

In the urologic world, there is a longstanding bias that surgical removal of the prostate gland, or radical prostatectomy (RP), is the preferred treatment for prostate cancer (PCa). It is based in the outdated belief that all PCa is a) multifocal, and b) likely to spread beyond the gland if untreated. Thus, it seemed logical keep reading

Multiparametric MRI Before Prostate Biopsy: Dawn of a New Era

“Change is inevitable. Progress is optional.” Tony Robbins In medicine, change sometimes happens with two steps forward but one step back. For example, in the early 20th century, delivering babies in hospitals became more popular than home births in order to have “painless” births with anesthesia. However, for many women the higher complication and infection keep reading

Less Expensive MRI Rules Out Unnecessary Prostate Biopsy

Two problems face men who have a high PSA or abnormal digital rectal exam (DRE). First, they are often referred for a conventional TRUS needle biopsy of the prostate because there is suspicion of prostate cancer (PCa). Second, multiparametric MRI is considered too time-consuming and expensive for routine determination of the need for a biopsy. keep reading

How to Detect Cancer in Large Prostate Glands

There are so many benefits to detecting prostate cancer (PCa) using multiparametric MRI that it’s hard to single out just one. However, the merits of mpMRI to find PCa in large glands deserve a spotlight. First, a word about prostate size. An average adult gland in younger men is about 30 – 40cc, roughly the keep reading